本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fate Therapeutics Inc

1.13
-0.0400-3.42%
成交量:86.47万
成交额:97.48万
市值:1.31亿
市盈率:-0.98
高:1.17
开:1.15
低:1.10
收:1.17
52周最高:1.94
52周最低:0.6611
股本:1.16亿
流通股本:1.01亿
量比:0.61
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-1.1500
每股收益(LYR):-1.1500
净资产收益率:-51.84%
总资产收益率:-24.12%
市净率:0.63
市盈率(LYR):-0.98

数据加载中...

2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC问询函

Form CORRESP - Correspondence
2024/03/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities